期刊文献+

正交实验优选可注射载药凝胶Taxol/PECT体内抗肿瘤作用的给药方案 被引量:3

Orthogonal Preferred Injectable Gel Containing Drug-loaded Taxol/PECT in Vivo Anti-tumor Effect of Dosage Regimen
原文传递
导出
摘要 目的优化Taxol/PECT温敏性可注射原位载药凝胶体内抗肿瘤作用的给药方案。方法采用正交试验设计,用L9(34)正交表研究不同因素、不同水平对小鼠肿瘤抑瘤率和体质量增长率的影响,选取最优给药方案。结果综合对比分析,最优给药方案为给药剂量10 mg.kg 1,给药体积80μL.(10 g)1,于接种后4 d开始给药。结论该方案对小鼠肿瘤生长的抑制效果、体质量增长效果较好,可以考虑把该方案用于后续的实验研究。 OBJECTIVE To optimize the anti-tumor effect of dosage regimen of the Taxol/PECT temperature-sensitive injectable drug-loaded gel in vivo.METHODS With the method of orthogonl experimental design,the effect of different factors and levels on the mouse tumor growth inhibition rate and body weight were detected by the L9(34) orthogonal array,and the optimal dosage regimen was selected.RESULTS After a comprehensive comparative analysis,the optimal dosage regimen was obtained with the dosage of 10 mg·kg 1,volume 80 ?L·(10 g) 1,administered 4 d after vaccination.CONCLUSION The inhibitory effect of tumor growth and weight incresing is sort of nice,so the program could be considered for subsequent experiments.
出处 《中国现代应用药学》 CAS CSCD 2012年第5期419-422,共4页 Chinese Journal of Modern Applied Pharmacy
基金 国家"863"高技术研究发展计划项目(2009AA03Z313)
关键词 正交实验 原位凝胶 肿瘤 orthogonal experiment in situ gel tumor
  • 相关文献

参考文献2

二级参考文献69

共引文献15

同被引文献28

  • 1刘志东,丁平田,李佳玮,潘卫三.依诺沙星眼用缓释凝胶剂的体外研究[J].中国药学杂志,2004,39(11):834-836. 被引量:7
  • 2高斐,王东凯,罗立,徐松林,刘莱,徐飒.左氧氟沙星热敏型眼用凝胶的研制及体外释放研究[J].中国药房,2005,16(14):1057-1059. 被引量:42
  • 3曹维,童春晖,胡一桥.利巴韦林眼凝胶的研制及质量控制[J].中国新药杂志,2006,15(10):793-796. 被引量:8
  • 4徐晖,王绍宁,周力民,冯彩霞,唐星,郑俊民.丙烯酸-泊洛沙姆407共聚物的合成及其原位胶凝性质[J].沈阳药科大学学报,2006,23(7):421-424. 被引量:6
  • 5WEI G. A research of thermo-setting ophthalmic gel [D]. Shenyang: Shenyang Pharmaceutical University, 2002.
  • 6LI Y. Study on thiamphenicol pH-setting ophthalmic gel [D]. Shenyang: Shenyang Pharmaceutical University, 2006.
  • 7HAGERSTROM H, PAULSSON M, EDSMAN K. Evaluation of mucoadhesion for two polyelectrolyte gels in simulated physiological conditions using a rheological method [J]. Eur J Pharn Sci, 2000, 9(2): 301-309.
  • 8XIA M F. The study on compound methyl-sulphate neostigmine in situ ophthalmic gel [D]. Pharmaceutical College,浙江大学药学院,2008.
  • 9PEKKA J, KRISR1NNA J, ARTO U, et al. The use of cyclodextrins in ophthalmic formulation of dipivefrinn [J]. Inter J Pharm, 1997, 153(2): 225.
  • 10Ten Tije A J, Verweij J, Loos WJ,et a l. Pharmacological effects of formulation vehicles : implications for cancer chemotherapy [J]. Clin Pharmacokinet, 2003,42 (7) : 665-685.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部